FRANKLIN LAKES, N.J., May 13, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the global commercial launch of the world’s first cell analyzer featuring breakthrough spectral and real-time cell imaging technologies, enabling more researchers across a wider range of applications to uncover deeper insights and dynamics from cells once invisible in flow cytometry experiments – with increased ease and throughput.

A joint research team affiliated with UNIST has developed a 3D-printed artificial tumor tissue capable of replicating the in vivo conditions of patient-derived cancer cells. This innovative model not only simulates the tumor microenvironment but also integrates artificial intelligence (AI) technology that can predict patient prognosis solely from images of tumor growth.

Researchers at UCL and the Francis Crick Institute have, for the first time, identified the origin of cardiac cells using 3D images of a heart forming in real-time, inside a living mouse embryo.

Tivic Health Systems (Nasdaq:TIVC) filed a patent application for its vagus nerve stimulation (VNS) system.

A subsidiary of Tandem Diabetes Care (Nasdaq:TNDM) recently picked up FDA clearance for infusion technology to support insulin delivery

University of California, Los Angeles and University of California, San Diego researchers developed an injectable sealant for rapid hemostasis and tissue adhesion in soft, elastic organs.

Researchers find that DNA behaves differently when crowded by molecules, as in a cell

High-Precision Type 5 Indicator Enhances Patient Safety by Validating Steam Sterilization Cycles in Clinical Settings

Partnership Pioneers the First-Ever Certified Handheld Liquid Inhalation Device for Medical Use in Europe, Expanding Access to Innovative Treatment Options